v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Stockholders' equity, beginning of period (in shares) at Dec. 31, 2024   42,086,477      
Stockholders' equity, beginning of period at Dec. 31, 2024 $ 166,964 $ 4 $ 598,070 $ 244 $ (431,354)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options, net of shares withheld (in shares)   20,045      
Issuance of common stock upon exercise of stock options, net of shares withheld 103   103    
Issuance of common stock upon vesting of restricted stock units (in shares)   373,078      
Stock-based compensation 6,663   6,663    
Foreign currency translation 157     157  
Net unrealized loss on marketable securities (81)     (81)  
Net loss (6,542)       (6,542)
Stockholders' equity, end of period (in shares) at Mar. 31, 2025   42,479,600      
Stockholders' equity, end of period at Mar. 31, 2025 $ 167,264 $ 4 604,836 320 (437,896)
Stockholders' equity, beginning of period (in shares) at Dec. 31, 2025 43,647,131 43,647,131      
Stockholders' equity, beginning of period at Dec. 31, 2025 $ 177,532 $ 4 626,970 816 (450,258)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options, net of shares withheld (in shares) 7,346 7,346      
Issuance of common stock upon exercise of stock options, net of shares withheld $ 34   34    
Issuance of common stock upon vesting of restricted stock units (in shares)   546,996      
Stock-based compensation 6,025   6,025    
Foreign currency translation (160)     (160)  
Net unrealized loss on marketable securities (155)     (155)  
Net loss $ (4,334)       (4,334)
Stockholders' equity, end of period (in shares) at Mar. 31, 2026 44,201,473 44,201,473      
Stockholders' equity, end of period at Mar. 31, 2026 $ 178,942 $ 4 $ 633,029 $ 501 $ (454,592)